Primary Thromboprophylaxis in People With Cancer-Where Next?

JAMA Oncol. 2023 Nov 1;9(11):1545-1546. doi: 10.1001/jamaoncol.2023.3569.

Author

Alok A Khorana^{1

2}

Affiliations

¹ Department of Hematology Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.
² Case Comprehensive Cancer Center, Cleveland, Ohio.

PMID: 37733351
DOI: 10.1001/jamaoncol.2023.3569

No abstract available

MeSH terms

Anticoagulants / adverse effects
Hospitalization
Humans
Neoplasms* / complications
Neoplasms* / drug therapy
Venous Thromboembolism* / drug therapy
Venous Thromboembolism* / etiology
Venous Thromboembolism* / prevention & control

Substances

Anticoagulants